Please login to the form below

Not currently logged in
Email:
Password:

antiplatelet

This page shows the latest antiplatelet news and features for those working in and with pharma, biotech and healthcare.

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Better times ahead, promises AZ as Crestor drop outweighs new drugs

Among the company’s other growth products, antiplatelet drug Brilinta (ticagrelor) continued to perform as expected with a 24% sales increase to $293m.

Latest news

More from news
Approximately 3 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • Why health psychology is the answer to tackling adherence Why health psychology is the answer to tackling adherence

    In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet

  • Who tops the pharma list? Who tops the pharma list?

    The latter, an antiplatelet agent it co-marketed with Sanofi, enjoyed 2011 sales of $9.4bn - but, with Plavix accounting for more than a third of BMS revenues in 2010, the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics